Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Levitzki, Alexander
and
Klein, Shoshana
2010.
Signal transduction therapy of cancer.
Molecular Aspects of Medicine,
Vol. 31,
Issue. 4,
p.
287.
Barrett, A John
and
Battiwalla, Minoo
2010.
Relapse after allogeneic stem cell transplantation.
Expert Review of Hematology,
Vol. 3,
Issue. 4,
p.
429.
Ball, Edward D.
and
Elizabeth Broome, H.
2010.
Monoclonal antibodies in the treatment of hematologic malignancy.
Best Practice & Research Clinical Haematology,
Vol. 23,
Issue. 3,
p.
403.
Järås, Marcus
Johnels, Petra
Hansen, Nils
Ågerstam, Helena
Tsapogas, Panagiotis
Rissler, Marianne
Lassen, Carin
Olofsson, Tor
Bjerrum, Ole Weis
Richter, Johan
and
Fioretos, Thoas
2010.
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
Proceedings of the National Academy of Sciences,
Vol. 107,
Issue. 37,
p.
16280.
Kaneda, Yasufumi
2010.
A non-replicating oncolytic vector as a novel therapeutic tool against cancer.
BMB Reports ,
Vol. 43,
Issue. 12,
p.
773.
Pozzesi, N.
Pierangeli, S.
Vacca, C.
Falchi, L.
Pettorossi, V.
Martelli, M.P.
Thuy, T.T.
Ninh, P.T.
Liberati, A.M.
Riccardi, C.
Sung, T.V.
and
Delfino, D.V.
2011.
Maesopsin 4-O-β-D-Glucoside, a Natural Compound Isolated from the Leaves ofArtocarpus tonkinensis, Inhibits Proliferation and Up-Regulates HMOX1, SRXN1 and BCAS3 in Acute Myeloid Leukemia.
Journal of Chemotherapy,
Vol. 23,
Issue. 3,
p.
150.
Hwang, Ilseon
Kang, Yu Na
Kwon, Kun Young
Kwon, Sun Young
Kim, Sang Pyo
Lee, Sang Sook
Jung, Hye Ra
and
Choe, Mi Sun
2011.
Comparative Study of Relative Value for Diagnostic Procedure of Surgical Pathology in Korea and United States.
The Korean Journal of Pathology,
Vol. 45,
Issue. 1,
p.
9.
Tur, Mehmet Kemal
Huhn, Michael
Jost, Edgar
Thepen, Theo
Brümmendorf, Tim H.
and
Barth, Stefan
2011.
In vivo efficacy of the recombinant anti‐CD64 immunotoxin H22(scFv)‐ETA′ in a human acute myeloid leukemia xenograft tumor model.
International Journal of Cancer,
Vol. 129,
Issue. 5,
p.
1277.
Béné, M C
Nebe, T
Bettelheim, P
Buldini, B
Bumbea, H
Kern, W
Lacombe, F
Lemez, P
Marinov, I
Matutes, E
Maynadié, M
Oelschlagel, U
Orfao, A
Schabath, R
Solenthaler, M
Tschurtschenthaler, G
Vladareanu, A M
Zini, G
Faure, G C
and
Porwit, A
2011.
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.
Leukemia,
Vol. 25,
Issue. 4,
p.
567.
Mallikaratchy, Prabodhika R.
Ruggiero, Alessandro
Gardner, Jeffrey R.
Kuryavyi, Vitaly
Maguire, William F.
Heaney, Mark L.
McDevitt, Michael R.
Patel, Dinshaw J.
and
Scheinberg, David A.
2011.
A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia.
Nucleic Acids Research,
Vol. 39,
Issue. 6,
p.
2458.
Yu, Jianhua
Mitsui, Takeki
Wei, Min
Mao, Hsiaoyin
Butchar, Jonathan P.
Shah, Mithun Vinod
Zhang, Jianying
Mishra, Anjali
Alvarez-Breckenridge, Christopher
Liu, Xingluo
Liu, Shujun
Yokohama, Akihiko
Trotta, Rossana
Marcucci, Guido
Benson, Don M.
Loughran, Thomas P.
Tridandapani, Susheela
and
Caligiuri, Michael A.
2011.
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.
Journal of Clinical Investigation,
Vol. 121,
Issue. 4,
p.
1456.
Wayne, Alan S.
2012.
Childhood Leukemias.
p.
563.
Shashidharamurthy, Rangaiah
Bozeman, Erica N.
Patel, Jaina
Kaur, Ramneet
Meganathan, Jeyandra
and
Selvaraj, Periasamy
2012.
Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development.
Medicinal Research Reviews,
Vol. 32,
Issue. 6,
p.
1197.
Kaneda, Yasufumi
2012.
Virosome: A novel vector to enable multi-modal strategies for cancer therapy.
Advanced Drug Delivery Reviews,
Vol. 64,
Issue. 8,
p.
730.
Saar, Moran
Moskovich, Oren
and
Fishelson, Zvi
2012.
Mortalin Biology: Life, Stress and Death.
p.
129.
Carol, Hernan
Szymanska, Barbara
Evans, Kathryn
Boehm, Ingrid
Houghton, Peter J.
Smith, Malcolm A.
and
Lock, Richard B.
2013.
The Anti-CD19 Antibody–Drug Conjugate SAR3419 Prevents Hematolymphoid Relapse Postinduction Therapy in Preclinical Models of Pediatric Acute Lymphoblastic Leukemia.
Clinical Cancer Research,
Vol. 19,
Issue. 7,
p.
1795.
Singer, J.
and
Jensen‐Jarolim, E.
2014.
IgE‐based immunotherapy of cancer: challenges and chances.
Allergy,
Vol. 69,
Issue. 2,
p.
137.
Berges, Nina
Hehmann-Titt, Grit
Hristodorov, Dmitrij
Melmer, Georg
Thepen, Theo
and
Barth, Stefan
2014.
Human Cytolytic Fusion Proteins: Modified Versions of Human Granzyme B and Angiogenin Have the Potential to Replace Bacterial Toxins in Targeted Therapies against CD64+ Diseases.
Antibodies,
Vol. 3,
Issue. 1,
p.
92.
Saar Ray, Moran
Moskovich, Oren
Iosefson, Ohad
and
Fishelson, Zvi
2014.
Mortalin/GRP75 Binds to Complement C9 and Plays a Role in Resistance to Complement-dependent Cytotoxicity.
Journal of Biological Chemistry,
Vol. 289,
Issue. 21,
p.
15014.
Borowitz, Michael J.
2014.
Abeloff's Clinical Oncology.
p.
211.